LP(A) MEASUREMENT IN PRIMARY PREVENTION POPULATION MAY LEAD TO INCREASED UTILIZATION OF STATIN THERAPY, A REAL-WORLD EXPERIENCE
Therapeutic Area: ASCVD/CVD Risk Reduction Background: Lp(a) is an important independent risk factor for ASCVD, and Lp(a) lowering therapies are in development. We evaluated Lp(a) trends to review impact of Lp(a) testing on utilization of lipid lowering therapies. Methods: Lp(a) is an important inde...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-09-01
|
| Series: | American Journal of Preventive Cardiology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666667723000971 |